PH13955A - Novel heterocyclic derivatives of 1-(1,3- - Google Patents

Novel heterocyclic derivatives of 1-(1,3-

Info

Publication number
PH13955A
PH13955A PH20761A PH20761DA PH13955A PH 13955 A PH13955 A PH 13955A PH 20761 A PH20761 A PH 20761A PH 20761D A PH20761D A PH 20761DA PH 13955 A PH13955 A PH 13955A
Authority
PH
Philippines
Prior art keywords
heterocyclic derivatives
novel heterocyclic
novel
derivatives
heterocyclic
Prior art date
Application number
PH20761A
Other languages
English (en)
Inventor
L Backs
J Heeres
J Mostmans
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of PH13955A publication Critical patent/PH13955A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/101,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12Oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/20Free hydroxyl or mercaptan
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/24Radicals substituted by singly bound oxygen or sulfur atoms esterified

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PH20761A 1977-01-31 1978-01-14 Novel heterocyclic derivatives of 1-(1,3- PH13955A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76426577A 1977-01-31 1977-01-31
US05/853,726 US4160841A (en) 1977-01-31 1977-11-21 Heterocyclic derivatives of 1-(1,3-dioxolan-2-ylmethyl)-1H-imidazoles

Publications (1)

Publication Number Publication Date
PH13955A true PH13955A (en) 1980-11-12

Family

ID=27117425

Family Applications (1)

Application Number Title Priority Date Filing Date
PH20761A PH13955A (en) 1977-01-31 1978-01-14 Novel heterocyclic derivatives of 1-(1,3-

Country Status (24)

Country Link
US (1) US4160841A (da)
JP (1) JPS53101377A (da)
AT (1) AT367419B (da)
AU (1) AU511358B2 (da)
BE (1) BE863437A (da)
CA (1) CA1117534A (da)
CH (1) CH644117A5 (da)
DE (1) DE2803870A1 (da)
DK (1) DK42778A (da)
ES (1) ES466483A1 (da)
FI (1) FI62836C (da)
FR (1) FR2378780A1 (da)
GB (1) GB1594860A (da)
GR (1) GR66115B (da)
HU (1) HU177458B (da)
IE (1) IE46055B1 (da)
IL (1) IL53924A (da)
IT (1) IT1105153B (da)
LU (1) LU78969A1 (da)
NL (1) NL7801088A (da)
PH (1) PH13955A (da)
PT (1) PT67599B (da)
SE (1) SE439633B (da)
SU (1) SU703020A3 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4144346A (en) * 1977-01-31 1979-03-13 Janssen Pharmaceutica N.V. Novel 1-(1,3-dioxolan-2-ylmethyl)-1H-imidazoles
US4218458A (en) * 1978-06-23 1980-08-19 Janssen Pharmaceutica, N.V. Heterocyclic derivatives of (4-aryloxy-methyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles
EP0006722B1 (en) * 1978-07-03 1984-09-05 Janssen Pharmaceutica N.V. Derivatives of (4-(piperazin-1-yl-phenyloxymethyl)-1.3-dioxolan-2-ylmethyl)-1h-imidazoles and -1h-1.2.4-triazoles, their preparation and use as fungicides and bactericides
US4287195A (en) * 1978-07-14 1981-09-01 Janssen Pharmaceutica, N.V. Heterocyclic derivatives of [4-(piperazin-1-yl-phenyloxymethyl)-1,3-dioxolan-2-ylmethyl]-1H-imidazoles and 1H-1,2,4-triazoles
US4338327A (en) * 1978-10-06 1982-07-06 Janssen Pharmaceutica, N.V. Substituted 1-(2-aryl-1,3-dioxolan-2-ylmethyl)-1H-1,2,4-triazoles
US4402957A (en) * 1979-04-04 1983-09-06 Janssen Pharmaceutica N.V. Heterocyclic derivatives of [4-(piperazin-1-ylphenyloxymethyl)-1,3-dioxolan-2-ylmethyl]-1H-imidazoles and 1H-1,2,4-triazoles
DE3039087A1 (de) * 1980-10-16 1982-05-19 Hoechst Ag, 6000 Frankfurt 1-(1,3-dioxolan-2-ylmethyl)-azole, ihre salze, verfahren zu ihrer herstellung und ihre verwendung
DE3104380A1 (de) * 1981-02-07 1982-08-19 Bayer Ag, 5090 Leverkusen Antimikrobielle mittel
DE3104311A1 (de) * 1981-02-07 1982-08-19 Bayer Ag, 5090 Leverkusen 2-azolylmethyl-1,3-dioxolan- und -dioxan-derivate, verfahren zu ihrer herstellung und ihre verwendung als fungizide
US4456605A (en) * 1981-05-07 1984-06-26 Janssen Pharmaceutica N.V. Heterocyclic derivatives of [4-(piperazin-1-yl-phenyloxymethyl)-1,3-dioxolan-2-ylmethyl]-1H-imidazoles and 1H-1,2,4-triazoles
JPS59139380A (ja) * 1983-01-28 1984-08-10 Yoshiki Hamada 1,3―ジオキソランアシラート誘導体及びその製造法
US4619931A (en) * 1983-02-28 1986-10-28 Janssen Pharmaceutica, N.V. [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazoles
DE3484023D1 (de) * 1983-03-03 1991-03-07 Basf Ag Azolylmethylcycloalkane, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
DE3308554A1 (de) * 1983-03-10 1984-09-13 Hoechst Ag, 6230 Frankfurt 1-/1,3-dioxolan-2-ylmethyl)-azole, ihre salze, verfahren zu ihrer herstellung und ihre verwendung
JPS59205366A (ja) * 1983-04-12 1984-11-20 スミスクライン・ベツクマン・コ−ポレイシヨン ド−パミン−β−ヒドロキシラ−ゼ抑制物質
EP1326844A2 (en) 2000-10-16 2003-07-16 Chugai Seiyaku Kabushiki Kaisha Process for preparation of n-substituted 2-sulfanylimidazoles
US20050074494A1 (en) * 2003-10-06 2005-04-07 Xiu-Xiu Cheng Itraconazole immediate release formulation
EP1951679B1 (en) * 2005-08-18 2015-02-18 Synta Pharmaceuticals Corp. Imidazole compounds that modulate hsp90 activity
KR100793693B1 (ko) 2006-05-09 2008-01-10 (주)유케이케미팜 이트라코나졸의 개선된 제조 방법
CA2896155C (en) * 2012-12-25 2020-05-05 Hua Medicine Process for the preparation of 1-([1,3]dioxolan-4-ylmethyl)-1h-pyrazol-3-ylamine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3575999A (en) * 1968-08-19 1971-04-20 Janssen Pharmaceutica Nv Ketal derivatives of imidazole
US3936470A (en) * 1975-01-27 1976-02-03 Janssen Pharmaceutica N.V. 1,3-Dioxolan-2-ylmethylimidazoles
CA1065873A (en) * 1975-01-27 1979-11-06 Janssen Pharmaceutica Naamloze Vennootschap Imidazole derivatives
US4101665A (en) * 1975-10-06 1978-07-18 Janssen Pharmaceutica N.V. 1-(2-Ar-4-aryloxymethyl-1,3-dioxolan-2-ylmethyl)imidazoles

Also Published As

Publication number Publication date
IL53924A (en) 1981-12-31
FR2378780B1 (da) 1984-11-30
IE46055B1 (en) 1983-02-09
FR2378780A1 (fr) 1978-08-25
JPS6339595B2 (da) 1988-08-05
JPS53101377A (en) 1978-09-04
US4160841A (en) 1979-07-10
GB1594860A (en) 1981-08-05
AU511358B2 (en) 1980-08-14
CA1117534A (en) 1982-02-02
SE439633B (sv) 1985-06-24
PT67599B (en) 1980-01-14
IT7847838A0 (it) 1978-01-30
NL7801088A (nl) 1978-08-02
AU3285278A (en) 1979-08-09
PT67599A (en) 1978-02-01
FI62836C (fi) 1983-03-10
SE7801089L (sv) 1978-08-01
SU703020A3 (ru) 1979-12-05
BE863437A (nl) 1978-07-31
DE2803870A1 (de) 1978-08-03
IE780196L (en) 1978-07-31
IT1105153B (it) 1985-10-28
IL53924A0 (en) 1978-04-30
ES466483A1 (es) 1979-06-01
LU78969A1 (fr) 1978-06-21
CH644117A5 (de) 1984-07-13
DK42778A (da) 1978-08-01
FI780293A (fi) 1978-08-01
GR66115B (da) 1981-01-16
HU177458B (en) 1981-10-28
FI62836B (fi) 1982-11-30
AT367419B (de) 1982-07-12
ATA63778A (de) 1981-11-15

Similar Documents

Publication Publication Date Title
JPS5436290A (en) Heterocyclic compound
AU3921478A (en) 3,4,5 trihydroxypiperidine derivatives
PH13955A (en) Novel heterocyclic derivatives of 1-(1,3-
PH19534A (en) Heterocyclic derivatives
GB2030979B (en) Heterocyclic derivatives
PT67855A (en) 5-(4-(diarylmethyl)-1-piperazinylalkyl)benzimidazole derivatives
GB2023133B (en) Heterocyclic derivatives
IL59829A (en) Derivatives of 9,10-anthracene-bis-carboxaldehyde-bis-hydrazone
PH12622A (en) Derivatives of 1,2-dithiole
ZA801151B (en) Heterocyclic derivatives
IL55285A (en) Solutions of 9,10-dihydroergopeptide alkaloid derivatives
ZA782118B (en) New 3,5-disubstituted-1h-1,2,4-triazole derivatives
GB2007644B (en) Heterocyclic compounds
JPS55120571A (en) Heterocyclic derivative
JPS5488286A (en) Heterocyclic compound
GR65206B (en) Herbicidal derivative of 1,2,4-briazin-5-ons
GB2017104A (en) 4-thia-2,6-diaza-bicyclo-(3,2,0-)-heptane derivatives
JPS5427565A (en) Novel substituted heterocyclic compound
ZA78934B (en) Novel heterocyclic compounds
GB2008591B (en) 1,3-thiazolidin-2,4-dione derivatives
BG25287A1 (en) Derivatives of trans-2-amino-3,5,8-trihydroxy-1,2,3,4-tetrahydronaphtalina
ZA773350B (en) New 1-substituted derivatives of 2,2-diphenylcyclopropane
GB2061915B (en) Heterocyclic derivatives
AU514034B2 (en) N-alkyl derivatives of l-phenyl-2-amino-1, 3 propandiol
GB2011390B (en) Heterocyclic compounds

Legal Events

Date Code Title Description
AT Record of annual fee paiements

Year of fee payment: 16